BRAND LOYALTY, ENTRY, AND PRICE-COMPETITION IN PHARMACEUTICALS AFTER THE 1984 DRUG-ACT

被引:279
作者
GRABOWSKI, HG
VERNON, JM
机构
关键词
D O I
10.1086/467257
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:331 / 350
页数:20
相关论文
共 14 条
[1]  
CAVES RE, 1991, BROOKINGS PAP ECO AC, P1
[2]  
CONRAD CA, 1983, INT J IND ORGAN, V1, P353
[3]  
FRANK RG, 1991, 3803 NAT BUR EC RES
[4]   DYNAMIC LIMIT PRICING - OPTIMAL PRICING UNDER THREAT OF ENTRY [J].
GASKINS, DW .
JOURNAL OF ECONOMIC THEORY, 1971, 3 (03) :306-322
[5]  
GRABOWSKI H, 1986, AM ECON REV, V76, P195
[6]   A NEW LOOK AT THE RETURNS AND RISKS TO PHARMACEUTICAL RESEARCH-AND-DEVELOPMENT [J].
GRABOWSKI, H ;
VERNON, J .
MANAGEMENT SCIENCE, 1990, 36 (07) :804-821
[7]  
GRABOWSKI HG, 1979, LAW CONTEMP PROBL, V43, P43
[8]   PERSUASION OR INFORMATION - PROMOTION AND THE SHARES OF BRAND NAME AND GENERIC PHARMACEUTICALS [J].
HURWITZ, MA ;
CAVES, RE .
JOURNAL OF LAW & ECONOMICS, 1988, 31 (02) :299-320
[9]  
Masson A., 1985, GENERIC SUBSTITUTION
[10]  
Scherer F. M., 1990, IND MARKET STRUCTURE